HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Reiss Selected Research

Neoplasms (Cancer)

11/2023Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration.
7/2023Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV.
1/2021Risk for Non-AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy : A Multinational Prospective Cohort Study.
1/2021CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
1/2020Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studies.
1/2019Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus-infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.
1/2016Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?
4/2015Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study.
10/2013Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.
6/2011Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Reiss Research Topics

Disease

61Acquired Immunodeficiency Syndrome (AIDS)
01/2023 - 07/2002
32HIV Infections (HIV Infection)
10/2023 - 08/2002
28Infections
01/2022 - 08/2002
15Inflammation (Inflammations)
11/2023 - 04/2009
15Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 07/2002
13Viremia
01/2022 - 05/2008
13Myocardial Infarction
01/2018 - 11/2003
13Lipodystrophy
10/2012 - 07/2002
11Neoplasms (Cancer)
11/2023 - 06/2010
11Hypertension (High Blood Pressure)
12/2017 - 05/2003
9Cognitive Dysfunction
01/2020 - 01/2016
9Insulin Resistance
11/2016 - 02/2003
6Coinfection
07/2020 - 08/2008
6Tuberculosis (Tuberculoses)
01/2019 - 12/2005
5Dyslipidemias (Dyslipidemia)
01/2023 - 04/2007
5Hepatitis B
01/2019 - 08/2008
5Coronary Disease (Coronary Heart Disease)
12/2014 - 05/2003
5Diabetes Mellitus
10/2012 - 05/2003
4Frailty
01/2021 - 01/2016
4Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2021 - 08/2002
4Chronic Renal Insufficiency
10/2019 - 04/2012
4Stroke (Strokes)
08/2019 - 01/2013
4Disease Progression
07/2014 - 09/2007
3Weight Gain
10/2023 - 01/2021
3COVID-19
01/2023 - 01/2022
3Immune Reconstitution Inflammatory Syndrome
12/2019 - 08/2008
3Hepatocellular Carcinoma (Hepatoma)
01/2019 - 01/2016
3Hepatitis C
01/2019 - 01/2005
3Fibrosis (Cirrhosis)
01/2019 - 07/2012
3Opportunistic Infections (Opportunistic Infection)
03/2016 - 08/2002
3Osteoporosis
11/2015 - 02/2013
3Chronic Kidney Failure (Chronic Renal Failure)
01/2014 - 12/2010
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2010 - 03/2009
2Anus Neoplasms (Anal Cancer)
01/2023 - 04/2015
2AIDS Dementia Complex
01/2018 - 03/2011
2Genetic Predisposition to Disease (Genetic Predisposition)
11/2017 - 01/2012
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2016 - 07/2012
2Metabolic Bone Diseases (Osteopenia)
11/2015 - 02/2015
2Renal Insufficiency (Renal Failure)
07/2012 - 07/2002
2Body Weight (Weight, Body)
07/2010 - 05/2003
2Atherosclerosis
06/2010 - 07/2007
2Hypertriglyceridemia
06/2010 - 01/2006

Drug/Important Bio-Agent (IBA)

24RNA (Ribonucleic Acid)IBA
11/2023 - 04/2003
14Anti-HIV Agents (AIDS Drugs)IBA
10/2019 - 02/2009
13LipidsIBA
07/2022 - 07/2002
11Protease Inhibitors (Protease Inhibitor)IBA
10/2019 - 07/2002
10abacavir (Ziagen)FDA Link
01/2023 - 07/2004
10Ritonavir (Norvir)FDA Link
01/2018 - 05/2003
10Reverse Transcriptase InhibitorsIBA
01/2018 - 02/2003
9Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2008
8Tenofovir (Viread)FDA Link
01/2023 - 04/2012
8NucleosidesIBA
01/2018 - 02/2003
8Lamivudine (Epivir)FDA Link
01/2013 - 07/2007
7Triglycerides (Triacylglycerol)IBA
01/2017 - 02/2003
6LopinavirFDA Link
10/2021 - 02/2010
6Antihypertensive Agents (Antihypertensives)IBA
01/2018 - 01/2005
6Atazanavir Sulfate (Reyataz)FDA Link
01/2018 - 01/2013
6Stavudine (Zerit)FDA LinkGeneric
01/2016 - 06/2004
6CholesterolIBA
01/2014 - 02/2003
6Zidovudine (Retrovir)FDA LinkGeneric
04/2012 - 06/2004
6Nevirapine (Viramune)FDA Link
02/2010 - 07/2002
5Indinavir (Crixivan)FDA Link
10/2021 - 07/2002
5CreatinineIBA
01/2017 - 06/2006
5Mitochondrial DNA (mtDNA)IBA
01/2012 - 06/2004
4IntegrasesIBA
10/2023 - 01/2021
4Antiviral Agents (Antivirals)IBA
01/2022 - 07/2012
4C-Reactive ProteinIBA
01/2021 - 04/2009
4Didanosine (Videx)FDA LinkGeneric
01/2016 - 09/2007
4HDL CholesterolIBA
07/2011 - 02/2003
4Lipoproteins (Lipoprotein)IBA
06/2010 - 07/2002
3tenofovir alafenamideIBA
10/2023 - 11/2015
3Glucose (Dextrose)FDA LinkGeneric
07/2022 - 01/2008
3efavirenz (Sustiva)FDA Link
07/2022 - 10/2016
3Darunavir (Prezista)FDA Link
10/2021 - 01/2018
3Indicators and Reagents (Reagents)IBA
06/2021 - 01/2008
3Lipopolysaccharide ReceptorsIBA
01/2021 - 12/2017
3AntigensIBA
01/2020 - 04/2009
3Alanine Transaminase (SGPT)IBA
01/2019 - 02/2013
3HIV Protease InhibitorsIBA
01/2018 - 01/2006
3insulin receptor-related receptor (IRR)IBA
01/2012 - 01/2008
2Immunoglobulin M (IgM)IBA
01/2023 - 01/2022
2Immunoglobulin G (IgG)IBA
01/2023 - 01/2022
2Messenger RNA (mRNA)IBA
01/2021 - 11/2016
2Integrase InhibitorsIBA
01/2021 - 12/2019
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 05/2008
2dolutegravirIBA
10/2019 - 01/2015
2Antidepressive Agents (Antidepressants)IBA
01/2018 - 12/2015
2Emtricitabine (Emtriva)FDA Link
11/2017 - 04/2012
2Retinaldehyde (Retinal)IBA
03/2016 - 01/2016
2Anti-Retroviral Agents (Antiretroviral Agents)IBA
01/2016 - 05/2008
2Nelfinavir (Viracept)FDA Link
01/2016 - 09/2007
2Surface Antigens (Surface Antigen)IBA
11/2015 - 03/2013
2N-acetoacetyl-N-deacetylcolchicineIBA
04/2015 - 10/2013
2Hepatitis B Surface Antigens (HBsAg)FDA Link
03/2013 - 01/2013
2LDL CholesterolIBA
06/2010 - 02/2003

Therapy/Procedure

72Therapeutics
10/2023 - 07/2002
60Highly Active Antiretroviral Therapy (HAART)
11/2021 - 07/2002
22Art Therapy
11/2023 - 01/2008
2Liver Transplantation
01/2019 - 01/2016
2Ambulatory Care (Outpatient Care)
01/2016 - 01/2013